Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zomedica Corp.TSSI · Entity 6884 | Director · CEO | May 08, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zomedica Corp.
Report date May 08, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, without par valueSEC Table I · non-derivative | Direct | 1,250,000 |
Reported balance
After 2026-05-08 transaction · row 1
1 source rowRow 1 · 2026-05-08 · Purchase · Acquired 250,000 · Balance 1,250,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2026 Filed May 8, 2026 20:15 UTC | Zomedica Corp. TSSI · Entity 6884 | PurchaseCommon Stock, without par value | 250,000 | $0.11 | $27,500.00 |
DisclosureSEC source: 0001654954-26-004631 · form4.xml · nonDerivative · entry 1 HEATON LARRY C II · CIK 0001213207 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250,000 Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:44 UTC | Zomedica Corp. ZOMDF · Entity 6884 | GrantOptions to buy Common Stock · Derivative | 4,000,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0001654954-25-007015 · section16.xml · derivative · entry 1 HEATON LARRY C II · CIK 0001213207 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000,000 Underlying: Common Stock · 4,000,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 6/11/2029 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:40 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 179,328 | $0.06 | $10,759.68 |
DisclosureSEC source: 0001654954-25-002960 · section16.xml · nonDerivative · entry 4 HEATON LARRY C II · CIK 0001213207 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:40 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 191,817 | $0.06 | $11,509.02 |
DisclosureSEC source: 0001654954-25-002960 · section16.xml · nonDerivative · entry 3 HEATON LARRY C II · CIK 0001213207 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 820,672 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:40 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 118,855 | $0.06 | $6,893.59 |
DisclosureSEC source: 0001654954-25-002960 · section16.xml · nonDerivative · entry 2 HEATON LARRY C II · CIK 0001213207 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 628,855 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:40 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 10,000 | $0.05 | $540.00 |
DisclosureSEC source: 0001654954-25-002960 · section16.xml · nonDerivative · entry 1 HEATON LARRY C II · CIK 0001213207 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 510,000 Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 11:11 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 100,000 | $0.12 | $12,200.00 |
DisclosureSEC source: 0001654954-24-014059 · section16.xml · nonDerivative · entry 1 HEATON LARRY C II · CIK 0001213207 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Read SEC document |
| September 05, 2024 Filed Sep 5, 2024 18:30 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 100,000 | $0.13 | $12,500.00 |
DisclosureSEC source: 0001654954-24-011544 · section16.xml · nonDerivative · entry 1 HEATON LARRY C II · CIK 0001213207 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 400,000 Read SEC document |
| May 13, 2024 Filed May 13, 2024 21:07 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 100,000 | $0.14 | $14,200.00 |
DisclosureSEC source: 0001654954-24-006092 · section16.xml · nonDerivative · entry 1 HEATON LARRY C II · CIK 0001213207 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Read SEC document |
| November 17, 2023 Filed Nov 17, 2023 21:50 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 100,000 | $0.17 | $16,600.00 |
DisclosureSEC source: 0001654954-23-014560 · section16.xml · nonDerivative · entry 1 HEATON LARRY C II · CIK 0001213207 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Read SEC document |
| May 26, 2023 Filed May 26, 2023 19:03 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 100,000 | $0.19 | $19,090.00 |
DisclosureSEC source: 0001654954-23-007292 · section16.xml · nonDerivative · entry 1 HEATON LARRY C II · CIK 0001213207 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
| October 04, 2022 Filed Oct 6, 2022 20:06 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOption to buy common stock · Derivative | 4,000,000 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001654954-22-013442 · section16.xml · derivative · entry 1 HEATON LARRY C II · CIK 0001213207 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000,000 Underlying: Common Stock · 4,000,000 shares Expires 2032-10-03 F1 · derivative.exercise_date: The stock option rest annually in 4 equal intallments commencing 10/4/2023. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 13:02 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 10,000,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001171843-21-006834 · ownership.xml · derivative · entry 1 HEATON LARRY C II · CIK 0001213207 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000,000 Underlying: Common Shares, without par value · 10,000,000 shares Expires 2031-10-01 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing October 1, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.